Why did 4572.T stock fall intraday today?

4572.T stock fell due to a gap-down on thin volume (32,600 shares) ahead of an earnings release and clinical catalysts. Low liquidity amplified selling, while no single broad-market healthcare shock was evident.

What are the near-term triggers for 4572.T stock?

Near-term triggers include the earnings announcement on 10 Feb 2026 and clinical updates for AS-0871, AS-0141 and AS-1763. Partner announcements or licensing deals could also move 4572.T stock materially.

How does Meyka AI view 4572.T stock right now?

Meyka AI rates 4572.T **61.37/100** (Grade B, HOLD). The model cites cash strength but flags negative EPS and high valuation. The monthly forecast is **JPY 433.33** and is a model projection, not a guarantee.

What is a sensible risk control for trading 4572.T stock?

Use tight position sizing and confirm moves with volume above the 50-day average. Place stop-losses near technical support levels and monitor earnings and clinical news, given 4572.T stock’s event-driven volatility.

JP Stocks

4572.T stock down 19% intraday: Carna Biosciences at JPY 334, analyst view

ByHuzaifa Zahoor February 2, 2026February 2, 2026

4572.T stock plunged 19.32% intraday to JPY 334.00 on the JPX as sellers dominated early trade. Volume was light at 32,600 shares versus an average of 712,177, pointing to low-liquidity pressure rather than broad sector selling. Traders are eyeing an upcoming earnings date on 10 Feb 2026 and clinical updates that could drive further moves. This intraday drop makes 4572.T stock one of the top losers on the Japan market today, and we use Meyka AI-powered market analysis platform data to trace drivers and near-term scenarios.